Our Travis Rieder explores why withdrawing from the agreement itself matters morally

Read More

At the Recode conference in Rancho Palos Verdes, California, Jesse Karmazin, who leads the small biotech startup Ambrosia, told New Scientist that he had positive results from a preliminary trial injecting older patients with younger plasma,the liquid part of blood that doesn’t contain any cells

Quick Read

Nor is the call to regulate it

Quick Read

Now, drug industry players are feuding over the windfall. Amid public concern over spiking drug prices, a powerful middleman is suing a tiny drugmaker over unpaid rebates and fees. The maker calls the suit baseless; analysts say the suit offers a window into an opaque world

Quick Read

You can add Ohio to the list of state and local governments that are filing lawsuits against drug makers for spreading the opioid epidemic by allegedly downplaying risks and improperly encouraging prescribing of the addictive painkillers

Quick Read

Here, two philosophers, Travis Rieder of the Johns Hopkins Berman Institute of Bioethics and Rebecca Kukla of the Kennedy Institute of Ethics at Georgetown, discuss the morality of deciding to have children in a world threatened by environmental degradation and the fraught ethics of encouraging people to opt for smaller families

Quick Read

Studies to treat vision loss and Parkinson’s disease are the first to proceed under new regulations

Quick Read

Our Travis Rieder joins The Climate Changer Podcast to discuss the moral dilemma of whether to have children in a resource-constrained, climate changing world

Read More